Last reviewed: February 2026

Normal Cells Barrett's Cells Squamous Columnar Normal lining Barrett's changes Chronic acid exposure

⚠️ What is Barrett's Esophagus?

Barrett's esophagus is a condition in which the normal squamous (flat, scale-like) cells lining the esophagus are replaced by columnar (column-shaped) cells similar to those found in the intestine. This cellular transformation, called intestinal metaplasia, occurs as a result of chronic acid exposure from long-term GERD.

Barrett's esophagus is significant because it's considered a precancerous condition—people with Barrett's have an increased risk of developing esophageal adenocarcinoma, a type of esophageal cancer. However, it's important to note that the absolute risk is still relatively low, and with proper surveillance, most cancers can be prevented or caught early.

📊
3-5%
Of GERD patients develop it
👨
2-3x
More common in men
📈
0.5%/year
Cancer progression risk
🔍
Surveillance
Key to prevention

Causes and Risk Factors

The Primary Cause: Chronic GERD

Barrett's esophagus develops when the esophagus is repeatedly exposed to stomach acid over many years. The body adapts to this hostile environment by replacing the normal esophageal cells with acid-resistant cells—a protective mechanism that unfortunately carries cancer risk.

Risk Factors

Risk Factor Details
Long-term GERD 5+ years of frequent heartburn significantly increases risk
Age Most commonly diagnosed in people 50+
Male sex 2-3 times more common in men
Caucasian ethnicity Higher risk in white populations
Obesity Especially abdominal obesity (central adiposity)
Smoking Current or past smoking increases risk
Family history Barrett's or esophageal cancer in relatives
Hiatal hernia Associated with more severe reflux
Interestingly, H. pylori infection (which causes ulcers) may actually be protective against Barrett's esophagus, possibly by reducing stomach acid production. However, this doesn't mean H. pylori infection is beneficial—it carries its own serious risks.

🔍 Symptoms

Barrett's esophagus itself typically causes no specific symptoms. Instead, people usually experience symptoms of the underlying GERD:

Paradox: Some people with Barrett's actually have fewer GERD symptoms because the new cells are more resistant to acid. This can be dangerous because the lack of symptoms may delay diagnosis. If you've had long-term GERD, don't assume improvement means you're "cured."

Warning Signs Requiring Immediate Evaluation

  • Progressive difficulty swallowing
  • Unintentional weight loss
  • Vomiting blood or material resembling coffee grounds
  • Black, tarry stools
  • Chest pain (rule out cardiac causes first)

🩺 Diagnosis

Barrett's esophagus is diagnosed through upper endoscopy with biopsy:

The Diagnostic Process

  1. Upper Endoscopy (EGD): A thin, flexible tube with a camera is passed through the mouth into the esophagus
  2. Visual Inspection: Barrett's tissue often appears salmon-colored (pink-red) compared to the normal pale pink esophageal lining
  3. Biopsy: Multiple tissue samples are taken from the abnormal-appearing area
  4. Histological Analysis: Pathologist examines cells under microscope for intestinal metaplasia and dysplasia

Classification of Barrett's

Finding What It Means Surveillance Interval
Non-dysplastic Barrett's Changed cells but no precancerous changes Every 3-5 years
Low-grade dysplasia (LGD) Mild precancerous changes Every 6-12 months, or treatment
High-grade dysplasia (HGD) Significant precancerous changes Treatment usually recommended
Intramucosal carcinoma Very early cancer confined to lining Treatment required

Who Should Be Screened?

Guidelines recommend considering screening endoscopy for people with:

💊 Treatment Options

For All Barrett's Patients

Treatment Based on Dysplasia Status

Non-Dysplastic Barrett's

Low-Grade Dysplasia

High-Grade Dysplasia

Endoscopic Treatment Options

Treatment Description
Radiofrequency Ablation (RFA) Uses heat energy to destroy Barrett's tissue; most common treatment
Cryotherapy Uses extreme cold to destroy abnormal cells
Endoscopic Mucosal Resection (EMR) Removes visible nodules or areas of concern
Photodynamic Therapy (PDT) Light-activated drug destroys abnormal cells (less commonly used)
After successful ablation, Barrett's tissue is replaced by normal esophageal cells. However, recurrence is possible, so ongoing surveillance and acid suppression remain important.

🎗️ Understanding the Cancer Risk

While Barrett's esophagus does increase cancer risk, it's important to put this in perspective:

The Numbers

Factors That Increase Progression Risk

Factors That May Reduce Risk

Surveillance endoscopies save lives by detecting dysplasia and early cancer when treatment is most effective. Adherence to surveillance schedules is crucial.

🏠 Living with Barrett's Esophagus

Daily Management

Emotional Considerations

Being diagnosed with a precancerous condition can cause significant anxiety. Remember:

Frequently Asked Questions

Can Barrett's esophagus be reversed?
Yes, in some cases. Endoscopic treatments like radiofrequency ablation can successfully eliminate Barrett's tissue, which is then replaced by normal cells. However, even after successful treatment, surveillance continues because recurrence is possible. Acid suppression alone typically doesn't reverse Barrett's but may help prevent progression.
Do I need to take PPIs forever?
Most experts recommend long-term PPI therapy for Barrett's patients. PPIs control acid reflux and may help prevent progression to dysplasia and cancer. While there are concerns about long-term PPI use, for most Barrett's patients, the benefits outweigh the risks. Discuss with your doctor if you have concerns.
How often do I need endoscopy?
Surveillance intervals depend on your findings: Non-dysplastic Barrett's: every 3-5 years. Low-grade dysplasia: every 6-12 months if not treated. After ablation treatment: at 3 months, then yearly for several years. Your doctor may adjust these based on your specific situation.
Should my family members be screened?
Having a family member with Barrett's or esophageal cancer does increase risk. First-degree relatives (parents, siblings, children) may benefit from screening, especially if they have GERD symptoms. Discuss this with their healthcare provider to determine if screening is appropriate.
What's the difference between Barrett's and esophageal cancer?
Barrett's esophagus is a precancerous condition—the cells have changed but are not yet cancerous. It can progress through stages (low-grade dysplasia, high-grade dysplasia) before becoming cancer. Most people with Barrett's never develop cancer, especially with proper surveillance and treatment of dysplasia when found.